DUE: September 7, 2026 The National Cancer Institute invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research.
DUE: August 31, 2028 Funding opportunity to develop strategies and interventions to improve diagnostic safety in the heterogenous ambulatory care environment.
DUE: September 7, 2026 Seeking applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy.
DUE: January 7, 2027 Funding available to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk
DUE: February 7, 2024 Funding available to provide a proof-of-principle for a novel strategy for Alzheimer Disease and Alzheimer Related Dementias (AD/ADRD) immunotherapies.
DUE: February 1, 2024 Supporting research designed to advance fundamental understanding of basic disease-related molecular mechanisms of vascular contributions to cognitive impairment and dementia (VCID).
DUE: February 14, 2024 Funding opportunity to support the development/enhancement of infrastructure (e.g., tools, surveys, biospecimens, data) for Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) neuroscience research in low- and middle-income countries (LMICs) in Africa.
Due: January 22, 2024 Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI) The Medical Technology Enterprise Consortium (MTEC) is excited to post this Request for Project Proposals (RPP) to solicit current MTEC members for a broad Read More
Due: November 13, 2023 The objective of this challenge is to develop initial proof of concept prototypes using Artificial Intelligence (AI) Large language models to automate the process of conducting ISD analysis, requirements development, for Read More
Due: November 14, 2023 This initiative seeks proposals from the small business community to support the development of compact tools and devices capable of manufacturing key chemical intermediates at the benchtop for research operations.
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.